Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Nektar Therapeutics (NKTR)

31.68   0.49 (1.57%) 04-18 16:00
Open: 31.22 Pre. Close: 31.19
High: 31.95 Low: 30.155
Volume: 3,747,607 Market Cap: 5516M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 32.024 - 32.237 32.237 - 32.428
Low: 29.651 - 29.914 29.914 - 30.151
Close: 31.262 - 31.688 31.688 - 32.074

Technical analysis

as of: 2019-04-18 4:37:56 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 40.16     One year: 43.22
Support: Support1: 30.16    Support2: 25.09
Resistance: Resistance1: 34.39    Resistance2: 37.00
Pivot: 34.35
Moving Average: MA(5): 32.98     MA(20): 33.83
MA(100): 37.92     MA(250): 49.86
MACD: MACD(12,26): -0.92     Signal(9): -0.78
Stochastic oscillator: %K(14,3): 19.54     %D(3): 30.39
RSI: RSI(14): 34.98
52-week: High: 92.17  Low: 29.22  Change(%): -63.3
Average Vol(K): 3-Month: 161568  10-Days: 148471

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
NKTR has closed above bottom band by 6.4%. Bollinger Bands are 20.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 18 Apr 2019 17:09:17 Z
Oversold Conditions For Nektar Therapeutics (NKTR)

Fri, 05 Apr 2019 16:01:39 Z
S&P 500 Movers: DOW, APA

Mon, 01 Apr 2019 13:23:29 Z
Implied RSP Analyst Target Price: $116

Sat, 30 Mar 2019 16:08:27 Z
Nektar (NKTR) Down 17.1% Since Last Earnings Report: Can It Rebound?

Thu, 28 Mar 2019 17:08:25 Z
Agree To Purchase Nektar Therapeutics At $27, Earn 18.3% Annualized Using Options

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 174.10
Shares Float (M) 171.10
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS 3.600
EPS Est. Current Year -0.980
EPS Est. Next Year -1.100
EPS Est. Next Quarter -0.350
Forward EPS -1.260
Book Value (p.s.) 3.680
PEG Ratio 1.72
Profit Margin
Operating Margin 57.65
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth -58.3
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) 718.21
Levered Free Cash Flow (M) 442.14

Stock Valuations

P/E 8.80
P/E Growth Ratio 0.02
P/BV 8.61
P/S 783449984.00
P/CF 7.68

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.